Cargando…

Quinolinecarboxamides Inhibit the Replication of the Bovine Viral Diarrhea Virus by Targeting a Hot Spot for the Inhibition of Pestivirus Replication in the RNA-Dependent RNA Polymerase

The bovine viral diarrhea virus (BVDV), a pestivirus from the family of Flaviviridae is ubiquitous and causes a range of clinical manifestations in livestock, mainly cattle. Two quinolinecarboxamide analogues were identified in a CPE-based screening effort, as selective inhibitors of the in vitro bo...

Descripción completa

Detalles Bibliográficos
Autores principales: Musiu, Simone, Castillo, Yunierkis Perez, Muigg, Alexandra, Pürstinger, Gerhard, Leyssen, Pieter, Froeyen, Mathy, Neyts, Johan, Paeshuyse, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144022/
https://www.ncbi.nlm.nih.gov/pubmed/32178258
http://dx.doi.org/10.3390/molecules25061283
_version_ 1783519751465598976
author Musiu, Simone
Castillo, Yunierkis Perez
Muigg, Alexandra
Pürstinger, Gerhard
Leyssen, Pieter
Froeyen, Mathy
Neyts, Johan
Paeshuyse, Jan
author_facet Musiu, Simone
Castillo, Yunierkis Perez
Muigg, Alexandra
Pürstinger, Gerhard
Leyssen, Pieter
Froeyen, Mathy
Neyts, Johan
Paeshuyse, Jan
author_sort Musiu, Simone
collection PubMed
description The bovine viral diarrhea virus (BVDV), a pestivirus from the family of Flaviviridae is ubiquitous and causes a range of clinical manifestations in livestock, mainly cattle. Two quinolinecarboxamide analogues were identified in a CPE-based screening effort, as selective inhibitors of the in vitro bovine viral diarrhea virus (BVDV) replication, i.e., TO505-6180/CSFCI (average EC(50) = 0.07 µM, SD = 0.02 µM, CC(50) > 100 µM) and TO502-2403/CSFCII (average EC(50) = 0.2 µM, SD = 0.06 µM, CC(50) > 100 µM). The initial antiviral activity observed for both hits against BVDV was corroborated by measuring the inhibitory effect on viral RNA synthesis and the production of infectious virus. Modification of the substituents on the quinolinecarboxamide scaffold resulted in analogues that proved about 7-fold more potent (average EC(50) = 0.03 with a SD = 0.01 µM) and that were devoid of cellular toxicity, for the concentration range tested (SI = 3333). CSFCII resistant BVDV variants were selected and were found to carry the F224P mutation in the viral RNA-dependent RNA polymerase (RdRp), whereas CSFCI resistant BVDV carried two mutations in the same region of the RdRp, i.e., N264D and F224Y. Likewise, molecular modeling revealed that F224P/Y and N264D are located in a small cavity near the fingertip domain of the pestivirus polymerase. CSFC-resistant BVDV proved to be cross-resistant to earlier reported pestivirus inhibitors (BPIP, AG110, LZ37, and BBP) that are known to target the same region of the RdRp. CSFC analogues did not inhibit the in vitro activity of recombinant BVDV RdRp but inhibited the activity of BVDV replication complexes (RCs). CSFC analogues likely interact with the fingertip of the pestivirus RdRp at the same position as BPIP, AG110, LZ37, and BBP. This indicates that this region is a “hot spot” for the inhibition of pestivirus replication.
format Online
Article
Text
id pubmed-7144022
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-71440222020-04-13 Quinolinecarboxamides Inhibit the Replication of the Bovine Viral Diarrhea Virus by Targeting a Hot Spot for the Inhibition of Pestivirus Replication in the RNA-Dependent RNA Polymerase Musiu, Simone Castillo, Yunierkis Perez Muigg, Alexandra Pürstinger, Gerhard Leyssen, Pieter Froeyen, Mathy Neyts, Johan Paeshuyse, Jan Molecules Article The bovine viral diarrhea virus (BVDV), a pestivirus from the family of Flaviviridae is ubiquitous and causes a range of clinical manifestations in livestock, mainly cattle. Two quinolinecarboxamide analogues were identified in a CPE-based screening effort, as selective inhibitors of the in vitro bovine viral diarrhea virus (BVDV) replication, i.e., TO505-6180/CSFCI (average EC(50) = 0.07 µM, SD = 0.02 µM, CC(50) > 100 µM) and TO502-2403/CSFCII (average EC(50) = 0.2 µM, SD = 0.06 µM, CC(50) > 100 µM). The initial antiviral activity observed for both hits against BVDV was corroborated by measuring the inhibitory effect on viral RNA synthesis and the production of infectious virus. Modification of the substituents on the quinolinecarboxamide scaffold resulted in analogues that proved about 7-fold more potent (average EC(50) = 0.03 with a SD = 0.01 µM) and that were devoid of cellular toxicity, for the concentration range tested (SI = 3333). CSFCII resistant BVDV variants were selected and were found to carry the F224P mutation in the viral RNA-dependent RNA polymerase (RdRp), whereas CSFCI resistant BVDV carried two mutations in the same region of the RdRp, i.e., N264D and F224Y. Likewise, molecular modeling revealed that F224P/Y and N264D are located in a small cavity near the fingertip domain of the pestivirus polymerase. CSFC-resistant BVDV proved to be cross-resistant to earlier reported pestivirus inhibitors (BPIP, AG110, LZ37, and BBP) that are known to target the same region of the RdRp. CSFC analogues did not inhibit the in vitro activity of recombinant BVDV RdRp but inhibited the activity of BVDV replication complexes (RCs). CSFC analogues likely interact with the fingertip of the pestivirus RdRp at the same position as BPIP, AG110, LZ37, and BBP. This indicates that this region is a “hot spot” for the inhibition of pestivirus replication. MDPI 2020-03-12 /pmc/articles/PMC7144022/ /pubmed/32178258 http://dx.doi.org/10.3390/molecules25061283 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Musiu, Simone
Castillo, Yunierkis Perez
Muigg, Alexandra
Pürstinger, Gerhard
Leyssen, Pieter
Froeyen, Mathy
Neyts, Johan
Paeshuyse, Jan
Quinolinecarboxamides Inhibit the Replication of the Bovine Viral Diarrhea Virus by Targeting a Hot Spot for the Inhibition of Pestivirus Replication in the RNA-Dependent RNA Polymerase
title Quinolinecarboxamides Inhibit the Replication of the Bovine Viral Diarrhea Virus by Targeting a Hot Spot for the Inhibition of Pestivirus Replication in the RNA-Dependent RNA Polymerase
title_full Quinolinecarboxamides Inhibit the Replication of the Bovine Viral Diarrhea Virus by Targeting a Hot Spot for the Inhibition of Pestivirus Replication in the RNA-Dependent RNA Polymerase
title_fullStr Quinolinecarboxamides Inhibit the Replication of the Bovine Viral Diarrhea Virus by Targeting a Hot Spot for the Inhibition of Pestivirus Replication in the RNA-Dependent RNA Polymerase
title_full_unstemmed Quinolinecarboxamides Inhibit the Replication of the Bovine Viral Diarrhea Virus by Targeting a Hot Spot for the Inhibition of Pestivirus Replication in the RNA-Dependent RNA Polymerase
title_short Quinolinecarboxamides Inhibit the Replication of the Bovine Viral Diarrhea Virus by Targeting a Hot Spot for the Inhibition of Pestivirus Replication in the RNA-Dependent RNA Polymerase
title_sort quinolinecarboxamides inhibit the replication of the bovine viral diarrhea virus by targeting a hot spot for the inhibition of pestivirus replication in the rna-dependent rna polymerase
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144022/
https://www.ncbi.nlm.nih.gov/pubmed/32178258
http://dx.doi.org/10.3390/molecules25061283
work_keys_str_mv AT musiusimone quinolinecarboxamidesinhibitthereplicationofthebovineviraldiarrheavirusbytargetingahotspotfortheinhibitionofpestivirusreplicationinthernadependentrnapolymerase
AT castilloyunierkisperez quinolinecarboxamidesinhibitthereplicationofthebovineviraldiarrheavirusbytargetingahotspotfortheinhibitionofpestivirusreplicationinthernadependentrnapolymerase
AT muiggalexandra quinolinecarboxamidesinhibitthereplicationofthebovineviraldiarrheavirusbytargetingahotspotfortheinhibitionofpestivirusreplicationinthernadependentrnapolymerase
AT purstingergerhard quinolinecarboxamidesinhibitthereplicationofthebovineviraldiarrheavirusbytargetingahotspotfortheinhibitionofpestivirusreplicationinthernadependentrnapolymerase
AT leyssenpieter quinolinecarboxamidesinhibitthereplicationofthebovineviraldiarrheavirusbytargetingahotspotfortheinhibitionofpestivirusreplicationinthernadependentrnapolymerase
AT froeyenmathy quinolinecarboxamidesinhibitthereplicationofthebovineviraldiarrheavirusbytargetingahotspotfortheinhibitionofpestivirusreplicationinthernadependentrnapolymerase
AT neytsjohan quinolinecarboxamidesinhibitthereplicationofthebovineviraldiarrheavirusbytargetingahotspotfortheinhibitionofpestivirusreplicationinthernadependentrnapolymerase
AT paeshuysejan quinolinecarboxamidesinhibitthereplicationofthebovineviraldiarrheavirusbytargetingahotspotfortheinhibitionofpestivirusreplicationinthernadependentrnapolymerase